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A novel aminoacyl-tRNA synthetase that contains an iron–sulfur cluster in the
tRNA anticodon-binding region and efﬁciently charges tRNA with tryptophan
has been found in Thermotoga maritima. The crystal structure of TmTrpRS
(tryptophanyl-tRNA synthetase; TrpRS; EC 6.1.1.2) reveals an iron–sulfur
[4Fe–4S] cluster bound to the tRNA anticodon-binding (TAB) domain and an
l-tryptophan ligand in the active site. None of the other T. maritima aminoacyl-
tRNA synthetases (AARSs) contain this [4Fe–4S] cluster-binding motif (C-x22-
C-x6-C-x2-C). It is speculated that the iron–sulfur cluster contributes to the
stability of TmTrpRS and could play a role in the recognition of the anticodon.
1. Introduction
Aminoacyl-tRNA synthetases (AARSs) covalently append amino
acids to their cognate tRNAs. This reaction proceeds in two steps.
The ﬁrst involves the activation of the amino acid by ATP to form
aminoacyl-adenylate, which then reacts with its corresponding tRNA
to form aminoacyl-tRNA. All organisms possess separate tRNA
synthetases for each of the 20 standard amino acids. AARSs are
grouped into two classes (classes I and II; Eriani et al., 1990) based on
similarities in their sequences and structures and each group contains
ten members. Class I AARSs are mostly monomeric and contain a
classic Rossmann nucleotide-fold catalytic domain and two highly
conserved sequence motifs ‘HIGH’ and ‘KMSKS’ that are critical for
their function. Class II AARSs are structurally distinct from their
class I counterparts; instead of the Rossmann fold they contain a
central antiparallel  -sheet ﬂanked by  -helices and are mostly
dimeric or multimeric. The reactions catalysed by the two classes
differ: in class I AARSs the aminoacyl group is coupled to the
20-hydroxyl of the tRNA, while in class II AARSs the 30-hydroxyl
is preferred. Tryptophanyl-tRNA synthetase (TrpRS; EC 6.1.1.2)
belongs to the class I AARSs and, as its name implies, catalyzes the
activation of tryptophan by ATP and the subsequent transfer of the
tryptophanyl moiety onto the cognate tRNA.
Here, we report a novel TrpRS from Thermotoga maritima that
contains a [4Fe–4S] cluster bound to the tRNA anticodon-binding
(TAB) domain and an l-tryptophan located in the active site. The
TmTrpRS structure was determined using the semi-automated high-
throughput pipeline of the Joint Center for Structural Genomics
(JCSG; Lesley et al., 2002) as part of the National Institute of General
Medical Sciences’ Protein Structure Initiative (PSI).
2. Materials and methods
2.1. Protein production and crystallization
TM0492 (GenBank AAD35577.1; gi:4981003; Swiss-Prot
Q9WYW2) was ampliﬁed by polymerase chain reaction (PCR) from
T. maritima MSB8 genomic DNA using PfuTurbo (Stratagene) and
primers (forward primer, 50-TTGAGAATACTGAGCGGCATGA-
GACC; reverse primer, 50-gagttaattaattaGAACATCAGGTTCAT-
GGCCCTTCTCAC; target sequence in upper case) corresponding to
the predicted 50 and 30 ends. The PCR product was cloned into
plasmid pMH2T7, which encodes a noncleavable expression and
puriﬁcation tag (MGSDKIHHHHHH) at the amino-terminus of the
full-length protein. The cloning junctions were conﬁrmed by DNAsequencing. Protein expression was performed in modiﬁed Terriﬁc
Broth using the Escherichia coli methionine-auxotrophic strain
DL41. At the end of fermentation, lysozyme was added to the culture
to a ﬁnal concentration of 250 mgm l
 1 and the cells were harvested.
After one freeze–thaw cycle, the cells were sonicated in lysis buffer
[50 mM Tris pH 7.9, 50 mM NaCl, 10 mM imidazole, 1 mM tris(2-
carboxyethyl)phosphine hydrochloride (TCEP)] and the lysate was
clariﬁed by centrifugation at 32 500g for 30 min. The soluble fraction
was applied onto nickel-chelating resin (GE Healthcare) pre-
equilibrated with lysis buffer, the resin was washed with wash buffer
[50 mM Tris pH 7.9, 300 mM NaCl, 40 mM imidazole, 10%(v/v)
glycerol, 1 mM TCEP] and the protein was eluted with elution buffer
[20 mM Tris pH 7.9, 300 mM imidazole, 10%(v/v) glycerol, 1 mM
TCEP]. The eluate was diluted tenfold with buffer Q [20 mM Tris pH
7.9, 5%(v/v) glycerol, 0.5 mM TCEP] containing 50 mM NaCl and
loaded onto a RESOURCE Q column (GE Healthcare) pre-
equilibrated with the same buffer. The protein was eluted with a
linear gradient of 50–500 mM NaCl in buffer Q, buffer-exchanged
with crystallization buffer [20 mM Tris pH 7.9, 150 mM NaCl, 0.5 mM
TCEP] and concentrated to 18 mg ml
 1 by centrifugal ultraﬁltration
(Millipore) for crystallization assays. TmTrpRS was crystallized by
mixing 200 nl protein solution with 200 nl crystallization solution and
equilibrating against 50 ml reservoir solution in the crystallization
plate (Greiner Crystal Quick 96LP) using the nanodroplet vapor-
diffusion method (Santarsiero et al., 2002) with standard JCSG
crystallization protocols (Lesley et al., 2002). The expression and
puriﬁcation tag was not removed from the protein prior to crystal-
lization. The crystallization reagent consisted of 12.5%(w/v) poly-
ethylene glycol 3000, 0.25 M MgCl2 and 0.1 M cacodylate pH 6.5. A
plate-shaped crystal of approximate dimensions 0.15   0.10  
0.02 mm was harvested after 18 d at 277 K for data collection.
Glycerol was diluted to 20%(v/v) using the reservoir solution and
then added in a 1:1 ratio to the drop as a cryoprotectant prior to
mounting. Initial screening for diffraction was carried out using the
Stanford Automated Mounting system (SAM; Cohen et al., 2002) at
the Stanford Synchrotron Radiation Lightsource (SSRL, Menlo Park,
California, USA). The diffraction data were indexed in the ortho-
rhombic space group C2221 (Table 1). The molecular weight and
oligomeric state of TmTrpRS in solution were determined using a
1   30 cm Superdex 200 column (GE Healthcare) coupled with
miniDAWN static light-scattering (SEC/SLS) and Optilab differential
refractive-index detectors (Wyatt Technology). The mobile phase
consisted of 20 mM Tris pH 8.0, 150 mM NaCl and 0.02%(w/v)
sodium azide.
2.2. Data collection, structure solution and refinement
Native diffraction data were collected on beamline 8.2.2 at the
Advanced Light Source (ALS, Berkeley, USA). The data sets were
collected at 100 Kusing an ADSC Quantum 315 CCD detector. Data
were integrated and reduced using XDS and scaled with the program
XSCALE (Kabsch, 1993, 2010a,b). The structure was determined
using the JCSG molecular-replacement pipeline (Schwarzenbacher
et al., 2008) with TrpRS_II from Deinococcus radiodurans
(DrTrpRS_II; Buddha & Crane, 2005b; PDB code 1yi8, chain B,
sequence identity of 43%) as a search model. The initial solution was
found using MOLREP (Vagin & Teplyakov, 1997). Model completion
was performed with Coot (Emsley & Cowtan, 2004). TLS reﬁnement
was performed with REFMAC5( W i n net al., 2003; three TLS groups;
group 1, residues 0–112; group 2, residues 120–196; group 3, residues
197–328 and the [4Fe–4S] cluster) using a maximum-likelihood target
function and individual B-factor reﬁnement with appropriate
restraints. Residues 113–119 were disordered and were not reﬁned.
CCP4 programs were used for data conversion and other calculations
(Collaborative Computational Project, Number 4, 1994). Data-
processing and reﬁnement statistics are summarized in Table 1.
2.3. Validation and deposition
The quality of the crystal structure was analyzed using the JCSG
Quality Control server (http://smb.slac.stanford.edu/jcsg/QC). This
server processes the coordinates and data through a variety of
validation tools including AutoDepInputTool (Yang et al., 2004),
MolProbity (Chen et al., 2010), WHAT IF 5.0 (Vriend, 1990),
RESOLVE (Terwilliger, 2003) and MOLEMAN2 (Kleywegt, 2000),
as well as several in-house scripts, and summarizes the results. Protein
quaternary-structure analysis was performed with the PQS server
(Henrick & Thornton, 1998). The sequence alignment was adapted
from an analysis using ClustalW (Larkin et al., 2007) and all other
ﬁgures were prepared with PyMOL (DeLano Scientiﬁc). Atomic
coordinates and experimental structure factors for TmTrpRS at
2.50 A ˚ resolution have been deposited in the PDB (http://
www.pdb.org) and are accessible under code 2g36.
2.4. Pyrophosphate-release assays
2.4.1. Aminoacylation assay. Aminoacylation assays were
performed with 50 mM HEPES pH 7.5, 20 mM KCl, 10 mM MgCl2,
4m M ATP, 1 mM [
3H]-l-Trp, 19 mM l-Trp, 2 mM DTT and 160 mM
bulk E. coli tRNA. The aminoacylation reactions were initiated by
structural communications
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Table 1
Summary of crystal parameters, data-collection and reﬁnement statistics for
TmTrpRS (PDB code 2g36).
Values in parentheses are for the highest resolution shell.
Space group C2221
Unit-cell parameters (A ˚ ) a = 122.89, b = 152.73, c = 53.07
Data collection  1
Wavelength (A ˚ ) 1.0000
Resolution range (A ˚ ) 29.64–2.50 (2.59–2.50)
No. of observations 63816
No. of reﬂections 17636
Completeness (%) 99.3 (97.9)
Mean I/ (I) 10.9 (2.3)
Rmerge on I† 0.10 (0.64)
Model and reﬁnement statistics
Resolution range (A ˚ ) 29.64–2.50
No. of reﬂections (total) 17623‡
No. of reﬂections (test) 894
Completeness (%) 99.3
Data set used in reﬁnement  1
Cutoff criterion |F|>0
Rcryst§ 0.19
Rfree} 0.26
Stereochemical parameters
Restraints (r.m.s.d. observed)
Bond lengths (A ˚ ) 0.013
Bond angles ( ) 1.60
Average isotropic B value, protein(A ˚ 2) 45.2
Average isotropic B value, ligands†† (A ˚ 2) 58.7
Average isotropic B value, water (A ˚ 2) 41.3
ESU‡‡ based on Rfree value (A ˚ ) 0.26
Protein residues/atoms 322/2563
Ligand/atoms 2/23
Solvent molecules 56
† Rmerge =
P
hkl
P
i jIiðhklÞ h IðhklÞij=
P
hkl
P
i IiðhklÞ. ‡ Typically, the number of
unique reﬂections used in reﬁnement is slightly less than the total number that were
integrated and scaled. Reﬂections are excluded owing to systematic absences, negative
intensities and rounding errors in the resolution limits and unit-cell parameters. § Rcryst
=
P
hkl
   jFobsj j Fcalcj
   =
P
hkl jFobsj, where Fcalc and Fobs are the calculated and observed
structure-factor amplitudes, respectively. } Rfree isthe same as Rcryst but for 5.1% of the
total reﬂections chosen at random and omitted from reﬁnement. †† l-Trp and iron–
sulfur cluster. ‡‡ Estimated overall coordinate error (Collaborative Computational
Project, Number 4, 1994; Cruickshank, 1999).the addition of 100 nM enzyme pre-incubated at either 310 or 333 K.
Samples were collected at various time points and quenched into a
PVDF Multiscreen ﬁlter plate containing 100 mM EDTA, 300 mM
sodium acetate pH 3.0 and 0.5 mg ml
 1 DNA as a carrier. Trichloro-
acetic acid was then added to each well at a 10% ﬁnal concentration
to precipitate the tRNA. The plate was then vacuum-dried and
washed four times with cold wash solution (5% trichloroacetic acid
and 100 mM cold l-Trp) to reduce the background radioactivity from
free [
3H]-l-Trp and once with 95% ethanol before scintillation
counting.
2.4.2. ATP–PPi exchange assay.P P i-exchange reactions were
performed in 100 mM HEPES pH 7.5, 20 mM KCl, 10 mM MgCl2,
2m M ATP, 2 mM sodium PPi,[
32P]-sodium PPi,2m M l-Trp and
5m M  -mercaptoethanol. Reactions were initiated by the addition
of 1 mM enzyme pre-incubated at either 310 or 333 K. At each time
point, samples were quenched into a PVDF Multiscreen ﬁlter plate
containing 4% charcoal, 1 M HCl, 200 mM sodium PPi. The charcoal
was collected and washed four times with 1 M HCl and 200 mM
sodium PPi prior to scintillation counting.
2.5. Comparison with other tRNA synthetases
An iterative PSI-BLAST (Altschul et al., 1997) search was
performed for 20 rounds of three iterations each against the NCBI
nonredundant (nr) protein-sequence database, using the trypto-
phanyl-tRNA synthetase sequence from T. maritima (gi:4981003) as
the initial query. The resulting list of homolog sequences was then
queried for the presence of the C-x6-C-x2-C pattern from the [4Fe–
4S] cluster-binding motif. False-positive hits that contained the Cys
pattern at a location other than the TAB region were discarded,
resulting in 85 sequences that contained the cluster-binding motif. In
addition, a PSI-BLAST ﬁltered search using only the C-x6-C-x2-C
pattern was performed using the sequence of TmTrpRS as a query.
An additional 22 unique sequences that were not identiﬁed by the
previous method were found. Moreover, to ensure that we had
exhaustively queried all proteins annotated as tryptophanyl-tRNA
synthetases that contained the [4F–4S] cluster-binding motif, a text
search was performed in which the nr database was mined for all
annotations containing ‘Tryptophan-tRNA synthetase’ and variants
thereof. The resulting sequences were then searched for the afore-
mentioned motif of interest. An additional 104 sequences were found
using this last approach that were not identiﬁed using the previous
methods. Although most organisms possess only a single copy of each
tRNA synthetase gene, two copies of TrpRS were detected in some
bacterial species. The sequences were further analyzed to determine
the distribution of the [4Fe–4S] cluster-binding motif. Alignment of
the resulting sequences is shown in Supplementary Fig. S1
1, where
only one representative sequence from a clustering at 50%
(sequences that are  50% identical are clustered as single repre-
sentative) is shown.
3. Results and discussion
3.1. Overall structure description
The 2.5 A ˚ resolution crystal structure of TmTrpRS was determined
by molecular replacement (MR) using DrTrpRS_II (PDB code 1yi8;
Buddha & Crane, 2005b) as a search model. The ﬁnal model contains
one TmTrpRS molecule (residues 0–328), one iron–sulfur cluster
[4Fe–4S], one tryptophan and 56 water molecules in the asymmetric
unit (Fig. 1). No interpretable electron density was observed for
residues  11 through  1 (from the expression and puriﬁcation tag)
and residues 113–119. The side chains of Lys12, Lys27, Glu74, Thr108,
Lys110, Glu111, Glu149, Asp150, Arg182, Lys185, Lys193, Lys209,
Glu210, Gu212, Gln213, Lys253, Glu257, Lys271, Lys307 and Lys315
were omitted owing to poor electron density. The Matthews coefﬁ-
cient (VM; Matthews, 1968) is 3.49 A ˚ 3 Da
 1 and the estimated solvent
content is 64.8%. The Ramachandran plot produced by MolProbity
shows that 97% of the residues are in favored regions, with no
outliers.
The TmTrpRS crystal structure, like other bacterial TrpRS struc-
tures, contains two domains. The N-terminal catalytic domain adopts
a canonical Rossmann nucleotide-binding fold (residues 1–181 and
296–328) with a central, ﬁve-stranded, parallel  -sheet ( 1– 5; the
structural communications
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Figure 1
Crystal structure of TmTrpRS. (a) Schematic representation of the TmTrpRS
crystallographic dimer. The  -helices are represented as cylinders in gray,  -strands
as arrows in purple and the loops in pink in one monomer (top) of the dimer. The
crystallographically related molecule below is color-coded from blue at the
N-terminus to red at the C-terminus. The bound 4Fe–4S cluster and l-tryptophan
are represented as sticks. The  -strands ( 1– 5) and  -helices ( 1– 15) are labeled
(310-helices are not labeled). The ATP-binding motifs (HIGH and KMSKS) are
highlighted in red. The short hinge region (residues 182–186) connecting the
Rossmann-fold and the TAB domains is indicated. (b) Close-up view of a 2Fo   Fc
OMIT map contoured at 1  showing the iron–sulfur cluster bound to the cysteine
motif [Cys236-x22-Cys259-x6-Cys266-x2-Cys269] in the anticodon-binding region
(top box) and the l-tryptophan found in the active site (bottom box). (c)
Comparison of TmTrpRS to the ‘open’ and ‘closed’ conformations of BsTrpRS.
1 Supplementary material has been deposited in the IUCr electronic archive
(Reference: WD5146).strand order is 32145) and a tRNA anticodon-binding (TAB) domain
that adopts an all-helical fold (residues 187–294) (Fig. 1). The TAB
domain is composed of four  -helices ( 11– 14) and two 310 helices
( 3 and  4) that are packed as a bundle. A short hinge region
(residues 182–186; Fig. 1a) connects the Rossmann-fold and the TAB
domains. The asymmetric unit contains one monomer of TmTrpRS,
which forms a crystallographic dimer across the twofold.
As per the SCOP classiﬁcation (Murzin et al., 1995), the catalytic
domain of TrpRSs belongs to the nucleotidylyl transferase super-
family. While all members of this superfamily retain the core
elements of the Rossmann fold, substantial insertions to the catalytic
domain, which confer novel functions, have been observed.
As expected, a structure-similarity search using DALI (Holm &
Sander, 1995) revealed extensive similarities to several class I
AARSs. Top DALI hits include TrpRS_II from D. radiodurans
(DrTrpRS_II; Buddha & Crane, 2005a; PDB code 1yid; Z = 39.7),
TrpRS from Bacillus stearothermophilus (BsTrpRS; Ilyin et al., 2000;
PDB code 1d2r; Z = 22.5) and human tyrosyl-tRNA synthetase
(HsTyrRS; Yang et al., 2003; PDB code 1q11; Z = 20.3), among many
other class I AARSs. The structural similarity between DrTrpRS-II
structural communications
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Figure 2
Comparison of TmTrpRS and DrTrpRS_II. (a) Structural superposition of TmTrpRS (gray), DrTrpRS_II + ATP and Mg (PDB code 1yid; green) and DrTrpRS_II + Trp
(PDB code 1yi8; blue). The bound ATP is shown as a stick model. The [4Fe–4S] cluster (orange and yellow), Mg ion (green sphere) and Trp (gray, red and blue) are shown as
spheres. The DrTrpRS_II structures superimpose with TmTrpRS over 319 C
  atoms with an r.m.s.d. of  1.7 A ˚ (45% sequence identity). (b) Electrostatic surface potential of
TmTrpRS calculated with the program APBS (Baker et al., 2001): positive potential is shown in blue (+3kTe
 1) and negative in red ( 3kTe
 1). l-Tryptophan and the iron–
sulfur cluster are shown as spheres. Note: the ATP-binding site is solvent-exposed, but the tryptophan and the iron–sulfur cluster are partially buried.and TmTrpRS is particularly high and a superimposition of the
structures based on secondary-structural elements from both the
catalytic Rossmann-fold domain and the C-terminal TAB domain
gives an r.m.s.d. of 1.7 A ˚ (Fig. 2).
Remarkably, the structure of TmTrpRS differs from other TrpRS
by the presence of an iron–sulfur cluster [4Fe–4S] in the C-terminal
TAB domain. In addition, an l-tryptophan molecule is bound in the
active site, which was not expected since tryptophan was not added to
any of the reagents used in crystallization or puriﬁcation.
3.2. [4Fe–4S] cluster-binding site
The [4Fe–4S] cluster is chelated by the side chains of Cys236,
Cys259, Cys266 and Cys269 from the TAB domain arranged in a
C-x22-C-x6-C-x2-C motif in which four irons are bound to the S atoms
of cysteines with distances of 2.28–2.34 A ˚ . The other signiﬁcant
interaction involves the NH1 atom of Arg224 and one of the S atoms
(S2) from the cluster, with a distance of 3.31 A ˚ (Fig. 1b). The presence
of the [4Fe–4S] cluster was ﬁrst identiﬁed based on electron density
and geometry. The presence of iron in the structure was then con-
ﬁrmed by X-ray ﬂuorescence scans (Supplementary Fig. S2; for
details of how ligands are identiﬁed at the JCSG in the course of
structure determination, see Kumar et al., 2010). Mass spectrometry
also corroborated the presence of the iron–sulfur cluster. Although
TmTrpRS shares extensive sequence similarity in the TAB region
with other TrpRSs, the C-x22-C-x6-C-x2-C motif is not found in any
other TrpRS present in the PDB. Sequences of TmTrpRS homologs
that possess the [4Fe–4S] cluster-binding motif are found in anaerobic
organisms from proteobacterial and archaeal groups, but no
structures of any of these have yet been reported. TmTrpRS is thus
the ﬁrst reported structure of a TrpRS that contains a [4Fe–4S]
cluster.
We extended our search to ﬁnd other potential iron–sulfur clusters
based on the presence of the cysteine-binding motif using SPASM
(Madsen & Kleywegt, 2002). For this search, the coordinates of the
four cysteines (Cys236, Cys259, Cys266 and Cys269) were used and
no substitutions of amino acids were allowed. SPASM identiﬁed 71
hits representing 22 unique proteins within a 1.5 A ˚ r.m.s.d. of the
target motif. The hits included the DNA-repair enzyme endonuclease
III (PDB code 2abk; Thayer et al., 1995), acetyl-CoA synthase (PDB
code 1ru3; Svetlitchnyi et al., 2004) and carbon monoxide dehy-
drogenase (PDB code 1jqk; Drennan et al., 2001). The top hit
containing the closest structural homolog was the E. coli DNA
glycosylase MutY (Guan et al., 1998; PDB code 1mun), which belongs
to the DNA-repair enzyme superfamily and excises adenine from
mispairs with 8-oxoguanine and guanine. Although the [4Fe–4S]
cluster-binding motif (C-x6-C-x2-C-x5-C) of E. coli MutY has, in
particular, a smaller sequence gap between the ﬁrst two Cys residues
than TmTrpRS (C-x22-C-x6-C-x2-C), the r.m.s.d. between the two
motifs was only 0.88 A ˚ .
Comparison of the TmTrpRS structure with that of the human
TrpRS–tRNA complex (PDB code 1r6t; Yang et al., 2006) reveals
that, although the sequence identity is very low (19%), the structures
are very similar, with an r.m.s.d. of 1.9 A ˚ for 238 superimposed C
 
atoms. A model of a TmTrRS–tRNA complex based on the complex
of human TrpRS with tRNA
Trp indicates that Cyt34 of the CCA
anticodon of tRNA
Trp can interact with the iron of the cluster via
Cys266 (Fig. 3a).
Interestingly, the T. maritima tRNA-modifying enzyme MiaB
(TmMiaB), which is involved in the post-transcriptional thiolation
and methylation of tRNA, contains an iron–sulfur cluster with a
(C-x3-C-x2-C) binding motif (Pierrel et al., 2003). The iron–sulfur
structural communications
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Figure 3
Model of the TmTrpRS–tRNA complex. (a) Overall view of the complex.
TmTrpRS is shown as a gray-blue ribbon and tRNA as an orange trace. The
anticodon bases, Cys266 and the [4Fe–4S] cluster are shown as stick models. Close-
up view of the interaction of TrpRS–tRNAwith the anticodon (CCA) region. Cyt34
of the tRNA molecule interacts with the iron of the cluster via Cys266. The model
was based on the structure of the human TrpRS–tRNA complex (PDB code 1r6t).
(b) Close-up view of the loop conformation of TmTrpRS (pink) near the [4Fe–4S]
cluster (pink sticks) compared with the helix (Asp382–Asn389) of the human
TrpRS–tRNA complex (gray–blue) and BsTrpRS (yellow).cluster in this case is essential for the modiﬁcation of the tRNA
adenine 37, which helps to stabilize the tRNA anticodon loop. This
reaction is catalyzed by the iron that is not coordinated to a cysteine,
which is a general theme for iron–sulfur clusters involved in catalysis.
In the case of the [4Fe–4S] cluster in TmTrpRS, we believe that
it plays a role in the recognition of speciﬁcally modiﬁed tRNA;
however, the biological implications of this are unknown at present.
Modiﬁcations of the nucleotide in the wobble position 34 are
common (Gustilo et al., 2008); for example, Saccharomyces cerevisiae
mitochondrial tRNA
Leu and tRNA
Trp contain a modiﬁed U at the
wobble position 34 (Martin et al., 1990). Moreover, 2-thiocytidine is
often found in the anticodon loop and all tRNA
Arg species from
structural communications
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Figure 4
Iron–sulfur cluster and l-tryptophan recognition of TmTrpRS and comparison with other TrpRSs. (a) Comparison of the TmTrpRS (magenta) and human TrpRS (blue) TAB
domains. The TmTrpRS iron–sulfur cluster is shown in orange ball-and-stick representation. (b) Comparison of the l-tryptophan recognition of TmTrpRS (magenta) and
BsTrpRS (yellow). (c) Comparison of the l-tryptophan recognition of human TrpRS (blue) and ScTrpRS (slate blue).E. coli (Ja ¨ger et al., 2004), for example, contain a 2-thiocytidine at
position 32.
An interesting difference in the TmTrpRS structure compared with
the human TrpRS–tRNA complex is the substitution of helix  17
(Asp382–Gln389) in the human enzyme with a loop in TmTrpRS
(Fig. 3b). As revealed in the crystal structure of the human TrpRS–
tRNA complex,  17 is involved in the recognition of the anticodon of
the tRNA (Yang et al., 2006). A similar conformational change has
been observed between BsTrpRS and the human enzyme (Fig. 3b). It
was suggested that tRNA binding to BsTrpRS may induce the human
enzyme-like conformation in this region (Yang et al., 2006). Inter-
estingly, the iron cluster is located near this loop. A PSI-BLAST
search for homologs of TmTrpRS in the NCBI nonredundant (nr)
protein-sequence database shows that the C-x(21–24)-C-x6-C-x2-C
motif is mostly found in thermophiles or other extremophiles
(Supplementary Fig. 1). Interestingly, this feature is found in organ-
isms that possess either a single TrpRS gene or multiple genes
encoding TrpRS. In those organisms that contain multiple TrpRS
genes, only one copy contains the [4Fe–4S] cluster-binding motif
(Supplementary Fig. S1).
3.3. ATP- and Trp-binding sites
TmTrpRS possesses ATP-binding and Trp-binding sites, which are
located close to each other in the Rossmann-fold domain. Typically,
this enzyme, which is an obligate dimer, binds ATP and l-tryptophan
in one subunit, while the tRNA anticodon region is recognized by the
TAB domain from the other subunit. Most class I AARSs are func-
tional as monomers, with the exceptions of TrpRS and TyrRS, which
are obligate homodimers. In TmTrpRS, the two relevant subunits
pack against each other, burying 2365 A ˚ 2 of mainly hydrophobic
surface. Although a single molecule is present in the asymmetric unit,
crystal-packing analysis identiﬁed a crystallographic dimer that is
likely to represent the biologically relevant dimer. Analytical size-
exclusion chromatography in combination with static light scattering
indicated that the major species in solution is a dimer.
Although Trp was not present in any of the crystallization reagents,
the structure revealed a bound l-tryptophan molecule in the Trp-
binding pocket of the active site (Fig. 1a), suggestive of tight binding
of TmTrpRS towards the substrate. The l-tryptophan-binding site in
the TmTrpRS structure is similar to that seen in the BsTrpRS and
human TrpRS structures (Figs. 4b and 4c; see also x3.4), as are the
relative orientations of the bound l-tryptophan. However, the
l-tryptophan recognition in TmTrpRS is more akin to that of
BsTrpRS than to that of human TrpRS.
The ATP-binding site is located in a positively charged, solvent-
exposed cleft located at the junction of the two domains (Fig. 2). It
contains the two signature sequences that are conserved across all
members of the class I AARSs: the
14HIGH
17 and
193KMSKS
197
motifs responsible for binding to the adenosine moiety of ATP
(Fig. 1a). The ATP-binding cleft opens and closes via a rotation about
a hinge between the Rossmann-fold domain and the anticodon-
recognition domain (Fig. 1c). In the TmTrpRS structure, which is
similar to the ‘open’ conformation of BsTrpRS, the KMSKS motif is
further from the ATP site and is not poised to bind ATP. Accordingly,
no ATP molecule was observed in the crystal.
TrpRS activity was conﬁrmed for TM0492. The activity was char-
acterized in tryptophan-dependent ATP–PPi exchange (1) and
aminoacylation assays (sum of equations 1 and 2),
TrpRS þ Trp þ ATP $ TrpRSðTrp AMPÞþPPi ð1Þ
TrpRSðTrp AMPÞþtRNA
Trp $ Trp tRNA
Trp þ AMP: ð2Þ
The overall aminoacylation of tRNA
Trp can be measured by the
incorporation of l-tryptophan into the tRNA to form Trp–tRNA
Trp
in the presence of ATP. Consistent with its thermophilic nature,
TmTrpRS has a more robust tRNA-charging activity at 333 K
compared with that at 310 K (Fig. 5a). The ATP–PPi exchange
reaction assesses the reverse of amino-acid activation by measuring
the incorporation of [
32P]-PPi into ATP (1). TM0492 was also active
in this assay at both 310 and 333 K (Fig. 5b). Although the amount of
[
32P]-ATP reached a lower plateau at 333 K than at 310 K, presum-
ably owing to the increase in ATP hydrolysis at higher temperature,
the initial PPi-exchange rate was higher at 333 K than at 310 K,
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Figure 5
Enzymatic activities of TmTrpRS. (a) Aminoacylation activity assayed at 310 and
333 K. Consistent with its thermophilic nature, TmTrpRS has a more robust tRNA-
charging activity at 333 K compared with that at 310 K. Control reaction assays
lacking enzyme or tRNA at 333 K are also shown. Points are the mean of two assays
and error bars represent the standard error of the mean of measurements. (b) ATP–
PPi-exchange activities assayed at 310 and 333 K. This experiment was only
performed once. Plots were derived by ﬁtting to an exponential rise to maximum
function. Control reaction assays lacking enzyme or Trp at 333 K are also shown.
Consistent with the observation of an endogenously bound Trp molecule in the
active site of its crystal structure, TmTrpRS had some PPi-exchange activity even
when no Trp was added to the reaction.consistent with the thermophilic nature of TM0492. Furthermore,
PPi-exchange activity was apparent even when no Trp was added to
the reaction (Fig. 4b). This result is consistent with the observation of
an endogenously bound tryptophan molecule in the active site of the
crystal structure.
3.4. Ligand-binding modes in TmTrpRS and human TrpRS
Structural comparison of the iron–sulfur cluster region of
TmTrpRS with that of human TrpRS shows that the chemical envir-
onment in this region is very different. There is nothing in the human
enzyme that replaces the iron–sulfur cluster. The four-cysteine motif
of TmTrpRS, Cys236, Cys259, Cys266 and Cys269, is not conserved in
the human enzyme (Fig. 4a). The corresponding residues in the
human enzyme are Asp397, Tyr420, Thr427 and Leu430, respectively
(Fig. 6). In addition, the side chains of Tyr420 and Thr427 overlap
with the iron–sulfur cluster of TmTrpRS (Fig. 4a).
Structural comparison of the l-tryptophan-binding pockets of
TmTrpRS and human TrpRS revealed that the orientations and
relative positions of the l-tryptophans are similar, but the inter-
actions between Trp and the binding-pocket residues differ.N
"1 of the
tryptophan interacts with Asp136 in TmTrpRS (Fig. 4b). This Asp is
conserved among prokaryotes (Fig. 6). In human TrpRS, N
"1 of the
tryptophan interacts with Tyr159 and Gln194 (Fig. 4c). These Tyr and
Gln residues are conserved in S. cerevisiae TrpRS as shown in the
recent structure (PDB code 3kt0; Zhou et al., 2010). l-Tryptophan
recognition in TrpRS is highly conserved among eukaryotes (Zhou et
al., 2010) and the interactions observed in TmTrpRS are conserved
among prokaryotes (Figs. 4b and 4c).
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Figure 6
Structure-based sequence alignment of TrpRSs. The four Cys residues in the C-x22-C-x6-C-x2-C motif of TmTrpRS that chelate the [4Fe–4S] cluster are colored by red letters.
Strictly conserved residues are highlighted in red boxes and additional conserved residues are in yellow boxes. The secondary-structure elements of TmTrpRS are shown at
the top, where  -helices ( 1– 15),  -strands ( 1– 5) and 310-helices ( 1– 4) are sequentially labeled and  -turns and  -turns are designated with the Greek letter tau (T).
Asp136, which is conserved among prokaryotes, is indicated with a blue diamond. Abbreviations: Thermotoga maritima TrpRS, TmTrpRS; Deinoccoccus radiodurans
TrpRS_I, Dr_I; Bacillus stearothermophilus TrpRS, Bs; D. radiodurans TrpRS_II, Dr_II; Homo sapiens TrpRS, Hs. Note: the sequence of DrTrpRS_I is included in the
alignment although there is no crystal structure available from the PDB.4. Conclusions
We report the ﬁrst structure of an iron–sulfur cluster-containing
tRNA synthetase. Interestingly, this structure also revealed an
l-tryptophan in the active site. The iron–sulfur cluster located in the
anticodon-binding region is coordinated by a four-cysteine motif
C-x22-C-x6-C-x2-C. The role of the iron–sulfur cluster is still not clear.
The complexity and energetic cost of synthesizing a [4Fe–4S] cluster
suggests that it may not be limited to performing a purely structural
role.
In a model of the TmTrpRS–tRNA complex based on the structure
of the human complex, the [4Fe–4S] cluster is within contact distance
of the tRNA anticodon (Fig. 3a). This implies that the iron–sulfur
cluster could be crucial for anticodon recognition by TmTrpRS. One
hypothesis is that the [4Fe–4S] cluster could be involved in recogni-
tion of a modiﬁed tRNA anticodon. However, the modiﬁcation state
of the tRNA
Trp anticodon of TmTrpRS–tRNA is not known.
Availability of more sequences and structures of [4Fe–4S] cluster
proteins might shed light on the evolutionary relationships of this
enzyme. The information presented here, in combination with further
biochemical and biophysical studies, should yield valuable insights
into the functional role of the enzyme. Additional information about
TM0492/TmTrpRS described in this study is available from TOPSAN
(Krishna et al., 2010; Weekes et al., 2010) at http://www.topsan.org/
explore?PDBid=2g36.
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